The Biotech Bottom, Bessent Backstop & Defensive Investing | Ep. 652

Why Biotech May Have Bottomed & The Underrated Role of Pharma Stocks

Apr 24, 2025

∙ Paid

Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was UP +7% and remains red at -10% for the year. Today’s newsletter will explore the tightening biotech funding landscape and what it means for startups navigating this new reality. Investors are d…

Keep reading with a 7-day free trial

Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.